Description

October is Liver Cancer Awareness Month, and EASL, along with other organisations such as Digestive Cancers Europe, International Liver Cancer Movement, and European Liver Patients Organisation are mounting an awareness campaign to shine a light on the growing burden of this disease. The prevalence of liver cancer is growing across Europe and disproportionately affects men; key drivers of the disease include alcohol consumption, obesity, and viral hepatitis infection. Watch on as Manon Allaire, representative from ILCM, speaks on the campaign for 2025.  

Acknowledgement: The EASL Policy Dialogues Season 4 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 4.

Manon Allaire

Dr Manon Allaire is Doctor of Medecine in La Pitié Salpétrière Hospital in Paris, headed by Pr Thabut. She focuses on teaching and research in hepatocellular carcinoma with focus in portal hypertension and systemic therapy. Dr Allaire obtained her medical degree in Hepatology and Gastroenterology in 2015 and her complementary medical degree in Medical Oncology in 2017. She is responsible of the Department of primary liver tumor in La Pitié Salpétrière Hospital, and of clinical and translational trials focus on primary liver tumour.

Dr Allaire is also member of the Proliferation, Stress and Liver Physiopathology unit in the group of Dr C. Desdouets in the Centre de Recherche des Cordeliers in Paris. Her team aim to study new immune biomarkers to predict response to immunotherapy and the impact of portal hypertension on the management of hepatocellular carcinoma. Dr. Allaire also plays an active role in international liver cancer research communities. She serves as part leader for advocacy within the International Liver Cancer Association (ILCA) and is a member of the International Liver Cancer Movement (ILCM).

Log in to post comments